Stock Analysis
- China
- /
- Medical Equipment
- /
- SHSE:688410
February 2025's Leading Growth Stocks With Strong Insider Confidence
Reviewed by Simply Wall St
As global markets grapple with geopolitical tensions and consumer spending concerns, major indices have experienced fluctuations, highlighting the volatility that investors must navigate. Amidst this backdrop, identifying growth companies with high insider ownership can provide a sense of stability and confidence, as such insider stakes often reflect strong belief in the company's potential despite broader market uncertainties.
Top 10 Growth Companies With High Insider Ownership
Name | Insider Ownership | Earnings Growth |
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) | 17.3% | 22.8% |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 50.1% |
Propel Holdings (TSX:PRL) | 36.5% | 38.1% |
Pricol (NSEI:PRICOLLTD) | 25.4% | 25.2% |
CD Projekt (WSE:CDR) | 29.7% | 39.4% |
On Holding (NYSE:ONON) | 19.1% | 29.8% |
Kingstone Companies (NasdaqCM:KINS) | 20.8% | 24.9% |
Pharma Mar (BME:PHM) | 11.9% | 45.4% |
Elliptic Laboratories (OB:ELABS) | 26.8% | 121.1% |
Plenti Group (ASX:PLT) | 12.7% | 120.1% |
Let's dive into some prime choices out of the screener.
Ningbo Lehui International Engineering EquipmentLtd (SHSE:603076)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Ningbo Lehui International Engineering Equipment Co., Ltd. (SHSE:603076) specializes in the design and manufacturing of equipment for the beverage and food industries, with a market cap of approximately CN¥2.76 billion.
Operations: Unfortunately, the provided text does not contain specific revenue segment data for Ningbo Lehui International Engineering Equipment Co., Ltd.
Insider Ownership: 21.2%
Ningbo Lehui International Engineering Equipment Ltd. shows strong growth potential with earnings forecasted to grow significantly at 63.4% annually, outpacing the broader CN market. Despite a slower revenue growth rate of 15.2%, it remains above the market average. However, challenges include a low forecasted Return on Equity of 7.9% and large one-off items impacting financial results, suggesting potential volatility in earnings quality without recent insider trading activity noted.
- Dive into the specifics of Ningbo Lehui International Engineering EquipmentLtd here with our thorough growth forecast report.
- Our valuation report here indicates Ningbo Lehui International Engineering EquipmentLtd may be overvalued.
SWS Hemodialysis Care (SHSE:688410)
Simply Wall St Growth Rating: ★★★★★☆
Overview: SWS Hemodialysis Care Co., Ltd. offers integrated blood purification solutions for renal failure and critically ill patients globally, with a market cap of CN¥3.31 billion.
Operations: SWS Hemodialysis Care Co., Ltd. generates its revenue through providing comprehensive blood purification services and solutions for patients with renal failure and critical illnesses on a global scale.
Insider Ownership: 37.3%
SWS Hemodialysis Care is positioned for robust growth with earnings expected to rise 42.36% annually, surpassing the broader CN market's growth. Revenue is also projected to expand at a strong pace of 33.2% per year. Despite trading at a significant discount to estimated fair value, challenges include a decline in profit margins from the previous year and low forecasted Return on Equity of 12.4%. Recent insider trading activity is not reported.
- Click to explore a detailed breakdown of our findings in SWS Hemodialysis Care's earnings growth report.
- Our comprehensive valuation report raises the possibility that SWS Hemodialysis Care is priced higher than what may be justified by its financials.
Shanghai Nenghui TechnologyLtd (SZSE:301046)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Shanghai Nenghui Technology Co., Ltd. is involved in the research, development, design, system integration, investment, and operation of photovoltaic power stations with a market cap of CN¥3.07 billion.
Operations: Shanghai Nenghui Technology Co., Ltd. generates its revenue through activities related to the research, development, and operation of photovoltaic power stations.
Insider Ownership: 32.4%
Shanghai Nenghui Technology Ltd. is poised for significant growth, with earnings projected to increase by 29.36% annually, outpacing the CN market's 25.4%. Revenue is expected to expand at a robust rate of 30.5% per year, exceeding the market average of 13.4%. Despite high non-cash earnings and a low future Return on Equity forecast of 14.6%, insider trading activity remains unreported recently. An upcoming shareholder meeting will address a new restricted stock incentive plan for 2024.
- Delve into the full analysis future growth report here for a deeper understanding of Shanghai Nenghui TechnologyLtd.
- According our valuation report, there's an indication that Shanghai Nenghui TechnologyLtd's share price might be on the expensive side.
Turning Ideas Into Actions
- Discover the full array of 1452 Fast Growing Companies With High Insider Ownership right here.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SHSE:688410
SWS Hemodialysis Care
Provides integrated blood purification solutions for renal failure and critically ill patients worldwide.